Oncology

Imugene onboards renowned cancer scientist Michael Caligiuri

Finfeed Archived Jan 07, 2019

Imugene (ASX:IMU) has appointed world-renowned cancer researcher, Professor Michael Caligiuri — President of the City of Hope National Medical Center in LA — to its Scientific Advisory Board (SAB).